GENE ONLINE|News &
Opinion
Blog

2019-09-10| InterviewsPolicy

Crowdsourcing, a Novel Data Sharing Strategy to Augment Patient Care: Interview with Dr. Alireza Haghighi at Harvard Medical School

by Rajaneesh K. Gopinath
Share To
Intensive research outcomes obtained using model organisms have certainly helped us take giant strides in mitigating life threatening diseases. Yet, it’s undeniable that they are imperfect substitutes for data obtained from humans. “We have been using models such as mice and zebrafish but there are big differences between these animals and humans. For a long time, we haven’t been paying enough attention to the importance of data even from a single patient” says Dr. Alireza Haghighi, Lead Clinical Molecular Geneticist of Harvard Brigham Genomic Medicine, an integrated clinical research program. He earnestly stressed how knowledge gained from a single individual could be a valuable resource in aiding the welfare of future patients.

It's free! Log in now to read

LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top